STERIS Net Profit Margin 2010-2023 | STE
Current and historical net profit margin for STERIS (STE) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. STERIS net profit margin for the three months ending June 30, 2023 was .
| STERIS Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-06-30 | $5.09B | $0.12B | 2.36% |
| 2023-03-31 | $4.96B | $0.11B | 2.16% |
| 2022-12-31 | $4.78B | $-0.03B | -0.59% |
| 2022-09-30 | $4.78B | $-0.01B | -0.17% |
| 2022-06-30 | $4.77B | $0.38B | 7.90% |
| 2022-03-31 | $4.59B | $0.24B | 5.32% |
| 2021-12-31 | $4.25B | $0.28B | 6.57% |
| 2021-09-30 | $3.85B | $0.25B | 6.50% |
| 2021-06-30 | $3.41B | $0.29B | 8.39% |
| 2021-03-31 | $3.11B | $0.40B | 12.81% |
| 2020-12-31 | $3.06B | $0.43B | 14.20% |
| 2020-09-30 | $3.02B | $0.42B | 14.03% |
| 2020-06-30 | $3.00B | $0.41B | 13.75% |
| 2020-03-31 | $3.03B | $0.41B | 13.46% |
| 2019-12-31 | $2.98B | $0.39B | 13.21% |
| 2019-09-30 | $2.90B | $0.34B | 11.59% |
| 2019-06-30 | $2.84B | $0.32B | 11.20% |
| 2019-03-31 | $2.78B | $0.30B | 10.89% |
| 2018-12-31 | $2.73B | $0.27B | 9.85% |
| 2018-09-30 | $2.70B | $0.32B | 11.72% |
| 2018-06-30 | $2.65B | $0.30B | 11.43% |
| 2018-03-31 | $2.62B | $0.29B | 11.11% |
| 2017-12-31 | $2.59B | $0.24B | 9.40% |
| 2017-09-30 | $2.57B | $0.14B | 5.56% |
| 2017-06-30 | $2.58B | $0.12B | 4.61% |
| 2017-03-31 | $2.61B | $0.11B | 4.17% |
| 2016-12-31 | $2.62B | $0.14B | 5.38% |
| 2016-09-30 | $2.59B | $0.17B | 6.40% |
| 2016-06-30 | $2.44B | $0.14B | 5.54% |
| 2016-03-31 | $2.24B | $0.11B | 4.96% |
| 2015-12-31 | $2.05B | $0.09B | 4.58% |
| 2015-09-30 | $1.91B | $0.11B | 5.88% |
| 2015-06-30 | $1.88B | $0.13B | 7.14% |
| 2015-03-31 | $1.85B | $0.14B | 7.29% |
| 2014-12-31 | $1.81B | $0.13B | 7.33% |
| 2014-09-30 | $1.75B | $0.12B | 7.10% |
| 2014-06-30 | $1.67B | $0.12B | 7.37% |
| 2014-03-31 | $1.62B | $0.13B | 8.01% |
| 2013-12-31 | $1.59B | $0.13B | 8.32% |
| 2013-09-30 | $1.56B | $0.15B | 9.68% |
| 2013-06-30 | $1.53B | $0.16B | 10.51% |
| 2013-03-31 | $1.50B | $0.16B | 10.59% |
| 2012-12-31 | $1.46B | $0.16B | 11.07% |
| 2012-09-30 | $1.44B | $0.15B | 10.29% |
| 2012-06-30 | $1.43B | $0.14B | 9.68% |
| 2012-03-31 | $1.41B | $0.14B | 9.74% |
| 2011-12-31 | $1.40B | $0.13B | 9.46% |
| 2011-09-30 | $1.37B | $0.12B | 8.77% |
| 2011-06-30 | $1.34B | $0.13B | 9.42% |
| 2011-03-31 | $1.21B | $0.05B | 4.31% |
| 2010-12-31 | $1.16B | $0.04B | 3.70% |
| 2010-09-30 | $1.16B | $0.06B | 5.34% |
| 2010-06-30 | $1.16B | $0.06B | 4.99% |
| 2010-03-31 | $1.26B | $0.13B | 10.25% |
| 2009-12-31 | $1.27B | $0.13B | 10.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.121B | $4.958B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $194.052B | 24.34 |
| Intuitive Surgical (ISRG) | United States | $101.273B | 72.23 |
| Edwards Lifesciences (EW) | United States | $42.347B | 27.53 |
| Alcon (ALC) | Switzerland | $38.349B | 33.87 |
| IQVIA Holdings (IQV) | United States | $36.391B | 21.79 |
| IDEXX Laboratories (IDXX) | United States | $36.162B | 46.25 |
| DexCom (DXCM) | United States | $33.939B | 77.43 |
| Hologic (HOLX) | United States | $17.197B | 18.09 |
| Waters (WAT) | United States | $15.899B | 22.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.545B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.110B | 15.51 |
| Sysmex ADR (SSMXY) | Japan | $10.492B | 30.88 |
| Teleflex (TFX) | United States | $9.587B | 15.35 |
| Penumbra (PEN) | United States | $9.514B | 298.23 |
| ShockWave Medical (SWAV) | United States | $7.147B | 30.29 |
| Abcam (ABCM) | United Kingdom | $5.170B | 0.00 |
| Globus Medical (GMED) | United States | $5.100B | 22.56 |
| Masimo (MASI) | United States | $5.039B | 25.04 |
| Glaukos (GKOS) | United States | $3.662B | 0.00 |
| Inari Medical (NARI) | United States | $3.645B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.139B | 11.86 |
| LivaNova (LIVN) | United Kingdom | $2.950B | 21.05 |
| Integer Holdings (ITGR) | United States | $2.631B | 19.41 |
| Elekta AB (EKTAY) | Sweden | $2.501B | 19.76 |
| Pacific Biosciences Of California (PACB) | United States | $2.240B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.160B | 16.77 |
| TransMedics (TMDX) | United States | $1.805B | 0.00 |
| Veracyte (VCYT) | United States | $1.635B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.536B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.460B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.340B | 0.00 |
| OPKO Health (OPK) | United States | $1.252B | 0.00 |
| Paragon 28 (FNA) | United States | $1.066B | 0.00 |
| RxSight (RXST) | United States | $0.969B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.948B | 13.58 |
| Treace Medical Concepts (TMCI) | United States | $0.823B | 0.00 |
| SiBone (SIBN) | United States | $0.818B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.764B | 0.00 |
| Nevro (NVRO) | United States | $0.696B | 0.00 |
| Artivion (AORT) | United States | $0.617B | 115.69 |
| Silk Road Medical (SILK) | United States | $0.610B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.608B | 16.83 |
| IRadimed (IRMD) | United States | $0.548B | 37.47 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.459B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.304B | 31.58 |
| CVRx (CVRX) | United States | $0.303B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
| Accuray (ARAY) | United States | $0.261B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.240B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.233B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.228B | 0.00 |
| AxoGen (AXGN) | United States | $0.208B | 0.00 |
| NeuroPace (NPCE) | United States | $0.204B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 11.91 |
| Anzu Special Acquisition Corp I (ANZU) | United States | $0.156B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.148B | 0.00 |
| Hyperfine (HYPR) | United States | $0.143B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.134B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.128B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.127B | 0.00 |
| Inogen (INGN) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.090B | 0.00 |
| DarioHealth (DRIO) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.085B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.081B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.063B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.063B | 0.00 |
| Vasomedical (VASO) | United States | $0.063B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.062B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.048B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Eargo (EAR) | United States | $0.046B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.044B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.043B | 18.71 |
| Neuronetics (STIM) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| PAVmed (PAVM) | United States | $0.036B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Sientra (SIEN) | United States | $0.031B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| PetVivo Holdings (PETV) | United States | $0.023B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.019B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| Nemaura Medical (NMRD) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
